18 results
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... amphotericin B, 3 to 5 mg/kg ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Acute Retroviral Syndrome
Acute Retroviral Syndrome is the symptomatic presentation of acute human immunodeficiency virus infection

 •
loss (>5 lb; 2.5 kg ... Presentations: • Opportunistic ... in which case opportunistic ... infections can ... HIV-1 p24 core Ag
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Tocilizumab 4-8mg/kg ... respiratory tract infection ... Siltuximab 11mg/kg ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Benznidazole 5–8 mg/kg ... Nifurtimox 8–10 mg/kg ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
Causes of Acute Pericarditis:

Infectious;

Viral: 
Adenovirus 
Coxsackie virus A and B 
Echovirus 
Epstein-Barr virus 
Hepatitis 
Human immunodeficiency
Pericarditis: Infectious ... Cardiac injury (e.g ... Pericardial perforation (e.g ... pericardial sac ... - related Medication
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Cytomegalovirus Infections ... other factors (e.g ... ., concomitant medications ... Treatment #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Treating Mild Infections ... amphotericin B 3–5 mg/kg ... deoxycholate 0.7–1.0 mg/kg ... Treatment #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Encephalitis in HIV-AIDS Indications ... Prevention #Treatment #opportunistic ... #infections #HIVAIDS ... #management #pharmacology ... #pharmacology
Complex Regional Pain Syndrome (CRPS) - Treatment
Non-Pharmacologic:
 • Education
 • Physical & occupational therapy
 • Psychology
Treatment Non-Pharmacologic ... behavioral therapy) Medications ... : • NSAID (e.g. ... antidepressants (e.g ... Trigger point injections